Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-04-25 | CYTOKINETICS INC | HENDERSON JOHN T
(Director) |
S | Common Stock | D | 10562 | $64.54 - $64.54 | $681,671 |
| 2024-04-09 | CYTOKINETICS INC | Malik Fady Ibraham
(EVP Research & Development) |
S | Common Stock | D | 32605 | $74.31 - $74.32 | $2,422,917 |
| 2024-04-09 | CYTOKINETICS INC | Malik Fady Ibraham
(EVP Research & Development) |
M | Common Stock | A | 28605 | $6.67 - $6.67 | $190,795 |
| 2024-03-14 | CYTOKINETICS INC | Wong Robert
(VP, Chief Accounting Officer) |
A | Common Stock | A | 4079 | $0.00 - $0.00 | $0 |
| 2024-03-14 | CYTOKINETICS INC | Callos Andrew
(EVP, Chief Commercial Officer) |
A | Common Stock | A | 16941 | $0.00 - $0.00 | $0 |
| 2024-03-14 | CYTOKINETICS INC | Malik Fady Ibraham
(EVP Research & Development) |
A | Common Stock | A | 21333 | $0.00 - $0.00 | $0 |
| 2024-03-14 | CYTOKINETICS INC | Blum Robert I
(President & CEO) |
A | Common Stock | A | 61490 | $0.00 - $0.00 | $0 |
| 2024-03-04 | CYTOKINETICS INC | Wong Robert
(VP, Chief Accounting Officer) |
F | Common Stock | D | 2640 | $66.88 - $67.68 | $177,989 |
| 2024-03-04 | CYTOKINETICS INC | Callos Andrew
(EVP, Chief Commercial Officer) |
F | Common Stock | D | 7305 | $66.88 - $67.68 | $490,319 |
| 2024-02-06 | CYTOKINETICS INC | Malik Fady Ibraham
(EVP Research & Development) |
S | Common Stock | D | 32605 | $79.28 - $79.30 | $2,585,496 |
| 2024-02-06 | CYTOKINETICS INC | Malik Fady Ibraham
(EVP Research & Development) |
M | Common Stock | A | 28605 | $6.67 - $6.67 | $190,795 |
| 2024-01-19 | CYTOKINETICS INC | Blum Robert I
(President & CEO) |
S | Common Stock | D | 12500 | $81.42 - $81.42 | $1,017,750 |
| 2024-01-19 | CYTOKINETICS INC | Blum Robert I
(President & CEO) |
M | Common Stock | A | 12500 | $6.67 - $6.67 | $83,375 |
| 2024-01-12 | CYTOKINETICS INC | HENDERSON JOHN T
(Director) |
S | Common Stock | D | 5000 | $85.14 - $85.14 | $425,700 |
| 2024-01-12 | CYTOKINETICS INC | HENDERSON JOHN T
(Director) |
M | Common Stock | A | 5000 | $4.44 - $4.44 | $22,200 |
| 2024-01-04 | CYTOKINETICS INC | Malik Fady Ibraham
(EVP Research & Development) |
S | Common Stock | D | 15678 | $86.98 - $86.99 | $1,363,712 |
| 2024-01-04 | CYTOKINETICS INC | Malik Fady Ibraham
(EVP Research & Development) |
M | Common Stock | A | 11678 | $7.96 - $7.96 | $92,956 |
| 2024-01-02 | CYTOKINETICS INC | Wysenski Nancy
(Director) |
A | Common Stock | A | 74 | $84.12 - $84.12 | $6,224 |
| 2024-01-02 | CYTOKINETICS INC | Blum Robert I
(President & CEO) |
S | Common Stock | D | 12500 | $85.08 - $85.08 | $1,063,500 |
| 2024-01-02 | CYTOKINETICS INC | Blum Robert I
(President & CEO) |
M | Common Stock | A | 12500 | $6.67 - $6.67 | $83,375 |
| 2023-12-27 | CYTOKINETICS INC | WIERENGA WENDALL
(Director) |
S | Common Stock | D | 10000 | $73.60 - $73.60 | $736,000 |
| 2023-12-27 | CYTOKINETICS INC | WIERENGA WENDALL
(Director) |
M | Common Stock | A | 10000 | $4.44 - $4.44 | $44,400 |
| 2023-12-18 | CYTOKINETICS INC | HENDERSON JOHN T
(Director) |
S | Common Stock | D | 2458 | $36.34 - $36.34 | $89,323 |
| 2023-12-18 | CYTOKINETICS INC | HENDERSON JOHN T
(Director) |
M | Common Stock | A | 13020 | $6.72 - $6.72 | $87,494 |
| 2023-11-30 | CYTOKINETICS INC | Blum Robert I
(President & CEO) |
S | Common Stock | D | 12500 | $32.99 - $32.99 | $412,375 |
| 2023-11-30 | CYTOKINETICS INC | Blum Robert I
(President & CEO) |
M | Common Stock | A | 12500 | $6.67 - $6.67 | $83,375 |
| 2023-11-09 | CYTOKINETICS INC | Malik Fady Ibraham
(EVP Research & Development) |
S | Common Stock | D | 2500 | $35.40 - $35.40 | $88,500 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |